ID MAR1_HUMAN Reviewed; 118 AA. AC Q16655; DT 01-NOV-1997, integrated into UniProtKB/Swiss-Prot. DT 01-NOV-1996, sequence version 1. DT 03-NOV-2009, entry version 67. DE RecName: Full=Melanoma antigen recognized by T-cells 1; DE Short=MART-1; DE Short=Melan-A protein; DE AltName: Full=Antigen SK29-AA; DE AltName: Full=Antigen LB39-AA; GN Name=MLANA; Synonyms=MART1; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; OC Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini; OC Catarrhini; Hominidae; Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA]. RC TISSUE=Melanoma; RX MEDLINE=94224770; PubMed=8170938; DOI=10.1073/pnas.91.9.3515; RA Kawakami Y., Eliyahu S., Delgado C.H., Robbins P.F., Rivoltini L., RA Topalian S.L., Miki T., Rosenberg S.A.; RT "Cloning of the gene coding for a shared human melanoma antigen RT recognized by autologous T cells infiltrating into tumor."; RL Proc. Natl. Acad. Sci. U.S.A. 91:3515-3519(1994). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA]. RX MEDLINE=94275389; PubMed=8006593; DOI=10.1084/jem.180.1.35; RA Coulie P.G., Brichard V., van Pel A., Woelfel T., Schneider J., RA Traversari C., Mattei S., de Plaen E., Lurquin C., Szikora J.-P., RA Renauld J.-C., Boon T.; RT "A new gene coding for a differentiation antigen recognized by RT autologous cytolytic T lymphocytes on HLA-A2 melanomas."; RL J. Exp. Med. 180:35-42(1994). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Skin; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA RT project: the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [4] RP SUBCELLULAR LOCATION. RX PubMed=11551907; DOI=10.1074/jbc.M103221200; RA Rimoldi D., Muehlethaler K., Salvi S., Valmori D., Romero P., RA Cerottini J.C., Levy F.; RT "Subcellular localization of the melanoma-associated protein Melan- RT AMART-1 influences the processing of its HLA-A2-restricted epitope."; RL J. Biol. Chem. 276:43189-43196(2001). RN [5] RP SUBCELLULAR LOCATION, AND ACYLATION. RX PubMed=12191019; RA De Maziere A.M., Muehlethaler K., van Donselaar E., Salvi S., RA Davoust J., Cerottini J.-C., Levy F., Slot J.W., Rimoldi D.; RT "The melanocytic protein Melan-A/MART-1 has a subcellular localization RT distinct from typical melanosomal proteins."; RL Traffic 3:678-693(2002). RN [6] RP FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SILV. RX PubMed=15695812; DOI=10.1074/jbc.M413692200; RA Hoashi T., Watabe H., Muller J., Yamaguchi Y., Vieira W.D., RA Hearing V.J.; RT "MART-1 is required for the function of the melanosomal matrix protein RT PMEL17/GP100 and the maturation of melanosomes."; RL J. Biol. Chem. 280:14006-14016(2005). CC -!- FUNCTION: Plays a vital role in the expression, stability, CC trafficking, and processing of melanocyte protein SILV/PMEL17, CC which is critical to the formation of stage II melanosomes. CC -!- SUBUNIT: Interacts with SILV/PMEL17. CC -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane; Single-pass CC type III membrane protein. Golgi apparatus. Golgi apparatus, CC trans-Golgi network membrane. Melanosome. Note=Also found in small CC vesicles and tubules dispersed over the entire cytoplasm. A small CC fraction of the protein is inserted into the membrane in an CC inverted orientation. Inversion of membrane topology results in CC the relocalization of the protein from a predominant Golgi/post- CC Golgi area to the endoplasmic reticulum. Melanoma cells expressing CC the protein with an inverted membrane topology are more CC effectively recognized by specific cytolytic T-lymphocytes than CC those expressing the protein in its native membrane orientation. CC -!- TISSUE SPECIFICITY: Expression is restricted to melanoma and CC melanocyte cell lines and retina. CC -!- PTM: Acylated. CC ----------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution-NoDerivs License CC ----------------------------------------------------------------------- DR EMBL; U06452; AAA19238.1; -; mRNA. DR EMBL; U06654; AAA20389.1; -; mRNA. DR EMBL; BC014423; AAH14423.1; -; mRNA. DR IPI; IPI00003426; -. DR PIR; A55253; A55253. DR RefSeq; NP_005502.1; -. DR UniGene; Hs.154069; -. DR PDB; 2GT9; X-ray; 1.75 A; C/F=26-35. DR PDB; 2GTW; X-ray; 1.55 A; C/F=28-35. DR PDB; 2GTZ; X-ray; 1.70 A; C/F=29-35. DR PDB; 2GUO; X-ray; 1.90 A; C/F=27-35. DR PDBsum; 2GT9; -. DR PDBsum; 2GTW; -. DR PDBsum; 2GTZ; -. DR PDBsum; 2GUO; -. DR STRING; Q16655; -. DR PhosphoSite; Q16655; -. DR PRIDE; Q16655; -. DR Ensembl; ENST00000381471; ENSP00000370880; ENSG00000120215; Homo sapiens. DR Ensembl; ENST00000381476; ENSP00000370885; ENSG00000120215; Homo sapiens. DR Ensembl; ENST00000381477; ENSP00000370886; ENSG00000120215; Homo sapiens. DR GeneID; 2315; -. DR KEGG; hsa:2315; -. DR UCSC; uc003zjo.1; human. DR CTD; 2315; -. DR GeneCards; GC09P005880; -. DR H-InvDB; HIX0007904; -. DR HGNC; HGNC:7124; MLANA. DR HPA; CAB000057; -. DR MIM; 605513; gene. DR PharmGKB; PA30842; -. DR HOGENOM; Q16655; -. DR HOVERGEN; Q16655; -. DR OMA; YRTLTDK; -. DR NextBio; 9401; -. DR ArrayExpress; Q16655; -. DR Bgee; Q16655; -. DR CleanEx; HS_MLANA; -. DR Genevestigator; Q16655; -. DR GermOnline; ENSG00000120215; Homo sapiens. DR GO; GO:0005789; C:endoplasmic reticulum membrane; IDA:UniProtKB. DR GO; GO:0005887; C:integral to plasma membrane; TAS:ProtInc. DR GO; GO:0042470; C:melanosome; IDA:UniProtKB. DR GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB. DR GO; GO:0005515; F:protein binding; IPI:UniProtKB. PE 1: Evidence at protein level; KW 3D-structure; Complete proteome; Endoplasmic reticulum; KW Golgi apparatus; Membrane; Transmembrane. FT CHAIN 1 118 Melanoma antigen recognized by T-cells 1. FT /FTId=PRO_0000096238. FT TRANSMEM 27 47 Potential. FT TOPO_DOM 48 118 Cytoplasmic (Potential). SQ SEQUENCE 118 AA; 13157 MW; B755BFF39CFCB16E CRC64; MPREDAHFIY GYPKKGHGHS YTTAEEAAGI GILTVILGVL LLIGCWYCRR RNGYRALMDK SLHVGTQCAL TRRCPQEGFD HRDSKVSLQE KNCEPVVPNA PPAYEKLSAE QSPPPYSP //